P. Schleckser

Five-year follow-up of the Sirolimus-Eluting Stents vs Vascular Brachytherapy for Bare Metal In-Stent Restenosis (SISR) trial.

P. Teirstein, L. Mauri, L. Satler, 2012, American heart journal.

Whole blood platelet function assay on the ICHOR point-of-care hematology analyzer.

M. Walsh, M. Corsello, K. Guyer, 1998, The journal of extra-corporeal technology.

Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial.

Hong Wang, Eugenia Nikolsky, Roxana Mehran, 2006, The American journal of cardiology.

3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.

P. Teirstein, L. Mauri, L. Satler, 2008, JACC. Cardiovascular interventions.